Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
- Products
-
- Cefixime for Oral Suspension USP
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
USA nationwide.
Nationwide
- Units affected
- 4554 bottles
- About this recall
- Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01